Logo wahanariau.com
  2. Numab therapeutics

Numab therapeutics

Index
Globenewswire

Numab Therapeutics and Kaken Pharmaceutical Announce Licensing and Co-development Agreement for Multispecific Antibody NM81 in Inflammatory Bowel Disease (IBD)

Kamis, 13 November 2025 - 23:20:36 Wib
Globenewswire

Numab Therapeutics and Kaken Pharmaceutical Enter Collaboration and Option Agreement for Multi-specific Antibody ND081 for Treatment of Inflammatory Bowel Disease

Jumat, 15 November 2024 - 17:00:00 Wib